Elisabeth Bloemena
- Otorhinolaryngology top 0.1%
- Head and Neck Cancer Studies 65
- Periodontics top 0.2%
- Oral Health Pathology and Treatment 29
- Oncology top 0.5%
- Ear and Head Tumors 24
- Viral-associated cancers and disorders 17
- Cancer Immunotherapy and Biomarkers 13
- Oral Surgery top 0.5%
- Oral and Maxillofacial Pathology 26
- Immunology top 1%
- Immune Cell Function and Interaction 15
-
- Salivary Gland Tumors Diagnosis and Treatment 45
- Co-authors
- C. René LeemansRuud H. BrakenhoffI. van der WaalS. G. M. MeuwissenChris J.L.M. MeijerHalil AkolMary PalmenLevinus A. Dieleman
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Elisabeth Bloemena
225 papers receiving 9.4k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Otorhinolaryngology 1.8k
- Periodontics 769
- Oncology 3.5k
- Oral Surgery 701
- Immunology 1.9k
Countries citing papers authored by Elisabeth Bloemena
This map shows the geographic impact of Elisabeth Bloemena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Bloemena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Bloemena more than expected).
Fields of papers citing papers by Elisabeth Bloemena
This network shows the impact of papers produced by Elisabeth Bloemena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Bloemena. The network helps show where Elisabeth Bloemena may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elisabeth Bloemena, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2024 | 7 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 11 | |
| 6 | 2022 | 26 | |
| 7 | 2021 | 14 | |
| 8 | 2021 | 50 | |
| 9 | 2021 | 7 | |
| 10 | 2019 | 17 | |
| 11 | 2019 | 9 | |
| 12 | 2018 | 24 | |
| 13 | Hepatocellular carcinoma: Dutch guideline for surveillance, diagnosis and therapy. | 2014 | 11 |
| 14 | 2013 | 51 | |
| 15 | 2011 | 66 | |
| 16 | 2011 | 54 | |
| 17 | Liver Histology of Ibd Patients Who Are Treated with 6-Thioguanine Due to Failure of Conventional Thiopurines Reveals Very Few Cases of Nodular Regenerative Hyperplasia | 2010 | 4 |
| 18 | 2009 | 61 | |
| 19 | 2008 | 27 | |
| 20 | 1998 | 112 |
About Elisabeth Bloemena
Elisabeth Bloemena is a scholar working on Otorhinolaryngology, Periodontics and Oral Surgery, having authored 231 papers that have together received 9.6k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (65 papers), Salivary Gland Tumors Diagnosis and Treatment (45 papers), Oral Health Pathology and Treatment (29 papers), Oral and Maxillofacial Pathology (26 papers), Ear and Head Tumors (24 papers), Viral-associated cancers and disorders (17 papers), Immune Cell Function and Interaction (15 papers) and Cancer Immunotherapy and Biomarkers (13 papers). The work is most often cited by research in Otorhinolaryngology (1.8k citations), Periodontics (769 citations) and Oncology (3.5k citations). Elisabeth Bloemena has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include C. René Leemans, Ruud H. Brakenhoff, I. van der Waal, S. G. M. Meuwissen, Chris J.L.M. Meijer, Halil Akol, Mary Palmen, Levinus A. Dieleman, E. P. van Rees and A. S. Peña. Their work appears in journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.